Patient Perceptions of Robotic, Endoscopic and Open Thyroid Surgery
Launched by SHANGHAI 6TH PEOPLE'S HOSPITAL · Jan 27, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how patients feel about different types of thyroid surgery: robotic, endoscopic, and traditional open surgery. The goal is to understand what concerns patients have when choosing a surgical method and how these feelings influence their preferences. Researchers hope that by learning more about patient attitudes, they can encourage the use of robotic thyroid surgery, which may offer benefits like less visible scarring and faster recovery.
To participate in this study, you need to have had thyroid surgery and be willing to fill out a questionnaire about your experiences and feelings regarding the surgery options. If you’re interested, you should be aware that the trial is currently looking for participants and welcomes individuals of all ages and genders. It's important that you complete the questionnaire thoroughly, as incomplete responses may lead to exclusion from the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients underwent thyroid surgery and were willing to complete the questionnaire
- Exclusion Criteria:
- • The completeness of the questionnaire was less than 80%
- • Drop of follow-up
About Shanghai 6th People's Hospital
Shanghai 6th People's Hospital is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital focuses on a wide range of therapeutic areas, striving to enhance patient outcomes and contribute to medical knowledge. With a dedicated team of experienced researchers and clinicians, Shanghai 6th People's Hospital emphasizes rigorous scientific methodology and ethical standards, ensuring that all trials are conducted with the utmost integrity and patient safety in mind. Through collaboration with various stakeholders, the hospital aims to bridge the gap between clinical research and real-world application, ultimately improving healthcare delivery both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Ling Zhan, Dr
Principal Investigator
Shanghai 6th People's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported